A limited constitutional government calls for a rules-based, freemarket monetary system, not the topsy-turvy fiat dollar that now exists under central banking. This issue of the Cato Journal examines the case for alternatives to central banking and the reforms needed to move toward free-market money.
Americans are finally enjoying an improving economy after years of recession and slow growth. The unemployment rate is dropping, the economy is expanding, and public confidence is rising. Surely our economic crisis is behind us. Or is it? In Going for Broke: Deficits, Debt, and the Entitlement Crisis, Cato scholar Michael D. Tanner examines the growing national debt and its dire implications for our future and explains why a looming financial meltdown may be far worse than anyone expects.
The Cato Institute has released its 2014 Annual Report, which documents a dynamic year of growth and productivity. “Libertarianism is the philosophy of freedom,” Cato’s David Boaz writes in his book, The Libertarian Mind. “It is the indispensable framework for the future.” And as the new report demonstrates, the Cato Institute, thanks largely to the generosity of our Sponsors, is leading the charge to apply this framework across the policy spectrum.
Featuring Lorens Helmchen, Associate Professor of Health Administration and Policy, George Mason University; Mark V. Pauly, Bendheim Professor, Professor of Health Care Management, The Wharton School, University of Pennsylvania; moderated by Michael F. Cannon, Director of Health Policy Studies, Cato Institute.
Can Medicare vouchers, such as the proposal authored by House Budget Committee chairman Paul Ryan (R-WI) that has passed the House of Representatives, restrain Medicare spending without harming the health of enrollees? Health economist Lorens Helmchen suggests that cash payments to patients, either through a lump sum or negative co-payments, could allow Medicare to “spend less by paying more.” Health care experts will discuss the benefits and difficulties of such payments, particularly how they affect Medicare spending, patient choice, incentives for cost-effective treatment, and medical innovation.